All In MedTech

Device Trial Radar · NCT01146782

Study of a Sleep Apnea System for the Treatment of Obstructive Sleep Apnea

The ATLAST Trial - A Multicenter, Prospective Study of the Attune Sleep Apnea System for the Treatment of Obstructive Sleep Apnea (OSA)

Last checked: Nov 20, 2026Latest source record: Jun 30, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

367

Actual

Start

Jun 2010

Primary completion

Mar 2012

Study completion Mar 2012

Sponsor

Lead sponsor
ApniCure, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 22, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
Single (outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective study of the Attune Sleep Apnea System for the treatment of obstructive sleep apnea. The objective of the study is to demonstrate safety and effectiveness of the Attune Sleep Apnea System to support FDA marketing clearance of the device.

Conditions

  • Obstructive Sleep Apnea

Interventions

  • Attune Sleep Apnea SystemDevice

    Console and mouthpiece sleep apnea system

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical Success Defined as Apnea-hypopnea Index (AHI) Reduction of >50% and Treated AHI<20Time frame: first treatment night

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • REM Medical

    Phoenix, Arizona

  • Peninsula Sleep Center

    Burlingame, California

  • SRI

    Menlo Park, California

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.